CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Jacksonville, Florida, United States and 162 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Jacksonville, Florida, United States and 75 other locations
This study, ELU- FRα-1, is focused on adult subjects who have advanced, recurrent or refractory folate receptor alpha (FRα) overexpressing tumors con...
Phase 1, Phase 2
Jacksonville, Florida, United States and 17 other locations
The purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors an...
Phase 2
Jacksonville, Florida, United States and 79 other locations
-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...
Phase 1, Phase 2
Jacksonville, Florida, United States and 123 other locations
A Phase 1B/2A study will be conducted to establish safety and dose level of AMXT 1501 dicaprate in combination with IV DFMO, in cancer patie...
Phase 1, Phase 2
Jacksonville, Florida, United States and 6 other locations
TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase...
Phase 1
Fleming Island, Florida, United States and 39 other locations
does to the body besides treating the disease.Participants will have cancer that has spread in the body near where it started (locally advan...
Phase 1
Jacksonville, Florida, United States and 17 other locations
The purpose of the trial is to evaluate the safety of acasunlimab (also known as GEN1046) as monotherapy and in combination therapies in patients wit...
Phase 1, Phase 2
Jacksonville, Florida, United States and 56 other locations
This is a multi-center, open-label, first-in-human Phase 1 study evaluating the anti-programmed death receptor 1 (anti-PD-1) antibody dostarlimab (al...
Phase 1
Jacksonville, Florida, United States and 144 other locations
Clinical trials
Research sites
Resources
Legal